|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Type 2 diabetes,cardiovascular risk and the link to insulin resistance显示文摘 | Stolar MW Chilon RJ | 2003 | Clin Ther2003，25，： | 1 |
| 2 | Insulin resistance, diabetes, and the adipocyte显示文摘 | Stolar MW | 2002 | Am J Health Syst Pharm2002，59，9： | 1 |
| 3 | Type 2 diabetes,cardiovascular risk,and the link to insulin resistance显示文摘 | STOLAR MW CHILTON RJ | 2003 | Clin Ther2003，25，： | 1 |
| 4 | Type 2 diabetes, cardiovascular risk, and the link to insulin resistance显示文摘 | Stolar MW Chilton RJ | 2003 | Clin Ther2003，25，： | 1 |
| 5 | Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes 显示文摘 | Stolar MW Grimm M Chen S | 2013 | Diabetes Metab Syndr Obes2013，6，： | 1 |
| 6 | Insulin resistance, diabetes, and the adipo- cyte显示文摘 | Stolar MW | 2002 | Am J Health Syst Pharm2002，59，9： | 1 |
| 7 | Insulin resistance,diabetes,and the adipocyte显示文摘 | Stolar MW | 2002 | Am J Health Syst Pharm2002，59，9： | 1 |
| 8 | Defining and achieving treatment success in patients with type 2 diabetes mellitus显示文摘 | Stolar MW | 2010 | Mayo Clin Proc2010，85，12： | 1 |
| 9 | Type 2 diabetes, cardiovascular risk, and the link to insulin resistance显示文摘 | STOLAR MW CHILTON RJ | 2003 | Clin Ther2003，25，： | 1 |
| 10 | Insulin resistance,diabetes,and the adipocyte显示文摘 | Stolar MW | 2002 | Am JHealth Syst Pharm2002，59，9： | 1 |
| 11 | Insulin resistance,diabetes,and the adipocyte显示文摘 | Stolar MW | 2002 | Am JHealth Syst Pharm2002，9，1： | 1 |
| 12 | Insulin resistance, diabetes and the adipocyte显示文摘 | Stolar MW | 2002 | Am J Health Syst Pharm2002，59，9： | 1 |
| 13 | Insulin resistance, diabetes, and the adipocyte显示文摘 | Stolar MW | 2002 | Am J Health Syst Pharm2002，59，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员